Sardocor, a subsidiary wholly-owned by Medera (www.linkedin.com/company/medera-biopharmaceutical), is dedicated to the clinical development of novel therapies. Building upon Novoheart’s (www.linkedin.com/company/novoheart-limited) bioengineered human tissue-based assays for disease modelling and dr... Read more
This company has no teams yet